FeesSafety
Pluang+

Vallourec reports monthly update on total shares and voting rights as of September 30, 2026.

Company Fundamentals
27 Oct 2026, 00:00 WIB
Na
View Source
Neutral
Vallourec reports monthly update on total shares and voting rights as of September 30, 2026.

Vallourec released its monthly report detailing the total number of shares and voting rights composing its share capital as of September 30, 2026. The company disclosed 267,165,720 shares in circulation with 265,283,859 net voting rights exercisable at the general meeting. This update is part of regulatory compliance under French commercial law and AMF regulations, providing transparency to investors about the company's capital structure. Vallourec also maintains additional disclosure obligations regarding threshold crossings as per its statutes.

Vallourec's monthly report on share capital and voting rights is noted here for context. For readers following Basic Materials, here is Pluang's market snapshot as of Oct 26, 2026 21:51 WIB: Among 83 priced US stocks in the sector, 52 rose and 30 fell. Notable movers include Dow Inc (DOW) at USD 34.15 with a 1-day change of +4.71%, Ternium S.A. (TX) at USD 53.44 down 4.51%, and Vale SA (VALE) at USD 11.95 down 3.63%. The most notable figure is Dow Inc's 4.71% gain.

More News

Vallourec updates monthly voting rights and share capital data as of September 2026.

Vallourec updates monthly voting rights and share capital data as of September 2026.

Vallourec, a French company, released its monthly update on the total number of voting rights and shares comprising its share capital as of September 30, 2026. The company reported 267,165,720 outstanding shares with a net total of 265,283,859 voting...

Company Fundamentals
Neutral
22 minutes ago
Colorectal cancer market to grow significantly by 2036 with new targeted therapies and immunotherapies.

Colorectal cancer market to grow significantly by 2036 with new targeted therapies and immunotherapies.

The colorectal cancer market is projected to expand steadily through 2036, driven by rising global incidence and increased disease awareness. Advances in targeted therapies, immunotherapies, and biomarker-based treatments are reshaping patient care. ...

Market News
Bullish
22 minutes ago
Smithfield Foods launches $250K scholarship for business students at Christopher Newport University

Smithfield Foods launches $250K scholarship for business students at Christopher Newport University

Smithfield Foods has created a $250,000 Future Leaders Scholarship program at Christopher Newport University to support eight incoming business students with $7,500 annual scholarships renewable for up to four years. The program aims to help local st...

Others
Bullish
2 hours ago
E-Power's Guizhou JV secures RMB 110M of RMB 200M capital raise, valuing it at RMB 2B post-money.

E-Power's Guizhou JV secures RMB 110M of RMB 200M capital raise, valuing it at RMB 2B post-money.

E-Power Inc.'s joint venture, Sunrise Guizhou, received RMB 110 million of a planned RMB 200 million capital increase, raising its registered capital and valuing the company at RMB 2 billion post-money. The funds will support business expansion, R&D,...

Company Fundamentals
Bullish
2 hours ago
Tallinna Sadam secures €50M loan to refinance bonds maturing in 2026, extending debt to 2031.

Tallinna Sadam secures €50M loan to refinance bonds maturing in 2026, extending debt to 2031.

AS Tallinna Sadam has signed a €50 million unsecured loan agreement with Swedbank, with a 5-year term and interest based on 3-month Euribor plus a margin. The loan will be fully drawn on October 26, 2026, and matures on October 26, 2031. This financi...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App